Through structure-baseddrug design of a small molecule that induces the DFG-out conformationof Aurora A kinase, lead compound 13 was identified,which potently (IC50 < 200 nM) inhibited the proliferationof high-MYC expressing small-cell lung cancer (SCLC) cell lines. This evidence concerns the gene MYC and small cell lung carcinoma.